Inventor
CHRISTOPHER MEHLIN
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides32%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C12NMicroorganisms or enzymes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
12,116,406Anti-CD33 antibodies and uses thereof202411,987,640Anti-mesothelin antigen-binding molecules and uses thereof202411,981,745Anti-mesothelin antigen-binding molecules and uses thereof202411,858,999IL-17 receptor A antigen binding proteins202411,648,290Cartilage-homing peptides202311,180,564IL-17 Receptor A antigen binding proteins2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to AMGEN K A INC (2)· patent assignee history
2021–2024Based in US· patent location history
2023–2024Patents assigned to FRED HUTCHINSON CANCER CENTER (3)· patent assignee history
2023Patents assigned to BLAZE BIOSCIENCE INC (1)· patent assignee history
2024Patents assigned to LINK IMMUNOTHERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FRED HUTCHINSON CANCER CENTER | 3 | 2023–2024 |
| AMGEN K A INC | 2 | 2021–2024 |
| BLAZE BIOSCIENCE INC | 1 | 2023 |
| LINK IMMUNOTHERAPEUTICS INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2024 |